The molecular bases of cystinuria and lysinuric protein intolerance

Current Opinion in Genetics and Development

Volumn 11, Issue 3, 2001, Pages 328-335

  Palacín, Manuel ^a   Borsani, Giuseppe ^b   Sebastio, Gianfranco ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; AMINO ACID TRANSPORTER; CYSTINE; GLYCINE; PROTEIN; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; AMINOACIDURIA; BRUSH BORDER; CYSTINURIA; DISEASE ASSOCIATION; EPITHELIUM CELL; EXON; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; GENOTYPE; INTESTINE ABSORPTION; INTRON; KIDNEY TUBULE ABSORPTION; METABOLIC TRANSPORT DISORDER; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTOLERANCE; REVIEW; RNA TRANSLATION;

EID: 0035371517     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(00)00198-2     Document Type: Review

References (55)

1. Palacín M., Estévez R., Bertran J., Zorzano A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev. 78:1998;969-1054.
2. +L/4F2hc is a heteromultimeric complex. FASEB J. 12:1998;1319-1329.
3. Palacín M., Estévez R., Zorzano A. Cystinuria calls for heteromultimeric amino acid transporters. Curr Opin Cell Biol. 10:1998;455-461.
4. Kanai Y., Segawa H., Miyamoto K.i, Uchino H., Takeda E., Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem. 273:1998;23629-23632.
5. Mastroberardino L., Spindler B., Pfeiffer R., Skelly P.J., Loffing J., Shoemaker C.B., Verrey F. Amino acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature. 395:1998;288-291.
6. +L. A candidate gene for lysinuric protein intolerance. J Biol Chem. 273:1998;32437-32445.
7. +LAT-2 by in silico cloning based on previous results [5]. Different mammalian LSHAT members induce different amino-acid transport activities when co-expressed with 4F2hc.
8. Sato H., Tamba M., Ishii T., Bannai S. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem. 274:1999;11444-11448. Identification of the LSHAT member xCT and the HSHAT member 4F2hc by full functional cloning in oocytes starting from cell mRNA.
9. Pineda M., Fernández E., Torrents D., Estévez R., López C., Camps M., Lloberas J., Zorzano A., Palacín M. Identification of a membrane protein (LAT-2) that co-expresses with 4F2hc an L type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem. 274:1999;19738-19744. Description of the human LSHAT member LAT-2. See also Segawa etal. [10•] and Rossier et al. [11•].
10. +-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem. 274:1999;19745-19751. Description of the human LSHAT member LAT-2. See also Pineda et al. [9•] and Rossier et al. [11•].
11. Rossier G., Meier C., Bauch C., Summa V., Sordat B., Verrey F., Kuhn L.C. LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine. J Biol Chem. 274:1999;34948-34954. Description of the human LSHAT member LAT-2. See also Pineda et al. [9•] and Segawa et al. [10•].
12. o,+AT; see Chairoungdua et al. [13•] and Pfeiffer et al. [14•].
13. o,+AT.
14. o,+AT.
15. +-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids. J Biol Chem. 275:2000;9690-9698. Reports cloning of the LSHAT member asc-1.
16. +-independent transporter for small neutral amino acids that transports d-serine with high affinity. Neurosci Lett. 287:2000;231-235.
17. - PfLügers. Archiv 2001, in press.
18. Verrey F., Jack D.L., Paulsen I.T., Saier M.H. Jr, Pfeiffer R. New glycoprotein-associated amino acid transporters. J Membr Biol. 172:1999;181-192.
19. Devés R., Boyd C.A. Surface antigen CD98 (4F2): not a single membrane protein, but a family of proteins with multiple functions. J Membr Biol. 173:2000;165-177.
20. Palacín M., Bertran J., Zorzano A. Heteromeric amino acid transporters explain inherited aminoacidurias. Curr Opin Nephrol Hypertens. 9:2000;547-553.
21. Pfeiffer R., Spindler B., Loffing J., Skelly P.J., Shoemaker C.B., Verrey F. Functional heterodimeric amino acid transporters lacking cystine residues involved in disulfide bond. FEBS lett. 439:1998;157-162.
22. Nakamura E., Sato M., Yang H., Miyagawa F., Harasaki M., Tomita K., Matsuoka S., Noma A., Iwai K., Minato N. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem. 274:1999;3009-3016.
23. Mannion B.A., Kolesnikova T.V., Lin S.H., Wang S., Thompson N.L., Hemler M.E. The light chain of CD98 is identified as E16/TA1 protein. J Biol Chem. 273:1998;33127-33129.
24. +LAT-1.
25. Sato H., Tamba M., Kuriyama-Matsumura K., Okuno S., Bannai S. Molecular cloning and expression of human xCT, the light chain of amino acid transport system xc-. Antiox Redox Signal. 2:2000;665-671.
26. +LAT2 transport characteristics.
27. o,+ amino-acid transporter bound simultaneously to their substrates at both sites of the plasma membrane.
28. + revisited: specificity and cation dependence of the interaction with neutral amino acids. J Membr Biol. 168:1999;199-208.
29. +L-like. A tertiary active transport mechanism for renal reabsorption of cystine and dibasic amino acids. J Biol Chem. 271:1996;17761-17770.
30. +L exchange activity represents the efflux of dibasic amino acids and the influx of neutral amino acids plus sodium.
31. Segal S., Thier S.O. Cystinuria. Scriver C.H., Beaudet A.L., Sly W.S., Valle D. Metabolic and Molecular Bases of Inherited Diseases. 1995;2479-2496 McGraw-Hill, New York.
32. Garrod A.E. Inborn errors of metabolism (lectures I-IV). Lancet. 2:1908;1-214.
33. Palacín M., Goodyer P., Nunes V., Gasparini P. Cystinuria. Scriver C.R., Beaudet A.L., Sly S.W., Valle D. Metabolic and Molecular Bases of Inherited Diseases. edn 8 :2001;4909-4932 McGraw-Hill, New York.
34. Goodyer P.R., Clow C., Reade T., Girardin C. Prospective analysis and classification of patients with cystinuria identified in a newborn screening program. J Pediatr. 122:1993;568-572.
35. Calonge M.J., Gasparini P., Chillarón J., Chillón M., Gallucci M., Rousaud F., Zelante L., Testar X., Dallapiccola B., Di Silveiro F., Barceló P., Estivill X., Zorzano A., Nunes V., Palacín M. Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat Genet. 6:1994;420-425.
36. Henthorn P.S., Liu J., Gidalevich T., Fang J., Casal M.L., Patterson D.F., Giger U. Canine cystinuria: polymorphism in the canine SLC3A1 gene and identification of a nonsense mutation in cystinuric Newfoundland dogs. Hum Genet. 107:2000;295-303. This paper describes the first animal model of cystinuria Type I, which is caused by mutations in SLC3A1.
37. Chillarón J., Estévez R., Samarzija I., Waldegger S., Testar X., Lang F., Zorzano A., Busch A., Palacín M. An intracellular trafficking defect in Type I cystinuria rBAT mutants M467T and M467K. J Biol Chem. 272:1997;9543-9549.
38. Saadi I., Chen X.Z., Hediger M., Ong P., Pereira P., Goodyer P., Rozen R. Molecular genetics of cystinuria: mutation analysis of SLC3A1 and evidence for another gene in Type I (silent) phenotype. Kidney Int. 54:1998;48-55.
39. Bisceglia L., Calonge M.J., Totaro A., Feliubadaló L., Melchionda S., García J., Testar X., Galucci M., Ponzone A., Zelante L., Zorzano A., Estivill E., Gasparini P., Nunes V., Palacín M. Localization, by linkage analysis, of the cystinuria Type III gene to chromosome 19q13.1. Am J Hum Genet. 60:1997;611-616.
40. Wartenfeld R., Golomb E., Katz G., Bale S.J., Goldman B., Pras M., Kastner D.L., Pras E. Molecular analysis of cystinuria in Libyan Jews: exclusion of the SLC3A1 gene and mapping of a new locus on 19q'. Am J Hum Genet. 60:1997;617-624.
41. Stoller M.L., Bruce J.E., Bruce C.A., Foroud T., Kirkwood S.C., Stambrook P.J. Linkage of Type II and Type III cystinuria to 19q13.1: codominant inheritance of two cystinuric alleles at 19q13.1 produces an extreme stone-forming phenotype. Am J Med Genet. 86:1999;134-139.
42. International Cystinuria Consortium ( Font M, Feliubadaló L, Estivill X, Nunes V, Golomb E, Kreiss Y, Pras E, Bisceglia L, d'Adamo AP, Zelante L, et al.: Functional analysis of mutations in SLC7A9, and genotype/phenotype correlation in non-Type I cystinuria. Hum Mol Genet 2001, 10:305-316. This paper shows genotype-phenotype correlation in non-Type-I cystinuria heterozygotes and contains the most up-to-date recompila of SLC7A9 mutations.
43. Furriols M., Chillarón J., Mora C., Castelló A., Bertran J., Camps M., Testar X., Vilaró S., Zorzano A., Palacín M. rBAT, related to L-cystine transport is localized to the microvilli of proximal straight tubules and its expression is regulated in kidney by development. J Biol Chem. 268:1993;27060-27068.
44. Pickel V.M., Nirenberg M.J., Chan J., Mosckovitz R., Udenfriend S., Tate S.S. Ultrastructural localization of a neutral and basic amino acid transporter in rat kidney and intestine. Proc Natl Acad Sci USA. 90:1993;7779-7783.
45. Kanai Y., Stelzner M.G., Lee W.S., Wells R.G., Brown D., Hediger M.A. Expression of mRNA (D2) encoding a protein involved in amino acid transport in S3 proximal tubule. Am J Physiol. 263:1992;F1087-F1093.
46. Simell O. Lysinuric protein intolerance and other cationic aminoacidurias. Scriver C.R., Beaudet A.L., Sly S.W., Valle D. Metabolic and Molecular Bases of Inherited Diseases. edn 8 :2001;4933-4956 McGraw-Hill, New York.
47. Santamaria F., Parenti G., Guidi G., Rotondo A., Grillo G., Larocca M.R., Celentano L., Strisciuglio P., Sebastio G., Andria G. Early detection of lung involvement in lysinuric protein intolerance: role of high resolution computed tomography and radioisotopic methods. Am J Respir Crit Care Med. 153:1996;731-735.
48. Lauteala T., Sistonen P., Savontaus M.L., Mykkanen J., Simell J., Lukkarinen M., Simell O., Aula P. Lysinuric protein intolerance (LPI) gene maps to the long arm of chromosome 14. Am J Hum Genet. 60:1997;1479-1486.
49. Lauteala T., Mykkanen J., Sperandeo M.P., Gasparini P., Savontaus M.L., Simell O., Andria G., Sebastio G., Aula P. Genetic homogeneity of lysinuric protein intolerance. Eur J Hum Genet. 6:1998;612-615.
50. +LAT-1) cause LPI.
51. +LAT-1) cause LPI.
52. Noguchi A., Shoji Y., Koizumi A., Takahashi T., Matsumori M., Kayo T., Ohata T., Wada Y., Yoshimura I., Maisawa S., Konishi M., Takasago Y., Takada G. SLC7A7 genomic structure and novel variants in three Japanese lysinuric protein intolerance families. Hum Mutat. 15:2000;367-372.
53. Sperandeo M.P., Bassi M.T., Riboni M., Parenti G., Buoninconti A., Manzoni M., Incerti B., Larocca M.R., Di Rocco M., Strisciuglio P., et al. Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance. Am J Hum Genet. 66:2000;92-99. Reports the high mutational heterogeneity of SLC7A7 in LPI and the lack of genotype-phenotype correlation.
54. Boyd C.A., Deves R., Laynes R., Kudo Y., Sebastio G. Cationic amino acid transport through system y?L in erythrocytes of patients with lysinuric protein intolerance. Pflugers Arch. 439:2000;513-516.
55. +)L in cultured human fibroblasts: normal phenotype of cells from LPI subjects. Am J Physiol Cell Physiol. 279:2000;1829-1837.